Search Results - "Minaeva, N. G."

Experimental Study of 99mTc-Metallothionein Biodistribution in Intact Animals by Tishchenko, V. K., Lebedeva, A. A., Fedorova, A. V., Orlenko, S. P., Minaeva, N. G., Shegai, P. V., Ivanov, S. A., Kaprin, A. D.

“…Metallothioneins are a special group of low-molecular-weight proteins with metal-binding properties, which make them promising chelators for the development of…”
Get full text

Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer by Severskaya, N. V., Erygin, D. V., Aleksandrov, Yu. V., Minaeva, N. G., Dvinskikh, N. Yu, Novikov, N. Yu

“…Carcinoembryonic antigen (CEA) is widely used to evaluate the effectiveness of treatment in patients with rectal cancer. The aim of the study was to…”
Get full text

Use of the new levodopa agent Stalevo (levodopa/carbidopa/entacapone) in the treatment of Parkinson's disease in out-patient clinical practice (the START-M open trial) by Boiko, A. N., Batysheva, T. T., Minaeva, N. G., Babina, L. A., Vdovichenko, T. V., Zhuravleva, E. Yu, Shikhkerimov, R. K., Malykhina, E. A., Khozova, A. A., Zaitsev, K. A., Kostenko, E. V.

“…Despite the significant symptomatic effects of levodopa, stable 24-h treatment responses are in the vast majority of patients replaced 2–3 years from the start…”
Get full text

CANCER-EMBRYONIC ANTIGEN IN PREDICTING THERAPEUTIC TUMOR PATHOMORPHISM AFTER NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH RECTAL CANCER by D. V. Erygin, N. G. Minaeva, S. A. Ivanov, N. Yu. Dvinskikh, N. Yu. Novikov, B. A. Berdov, A. A. Nevolskikh, A. A. Karpov, Yu. Yu. Mikhalev, I. A. Evtekhov, L. O. Petrov

“…The purpose of the study was to evaluate the prognostic significance of carcinoerembryonic antigen in patients with rectal cancer and correlate its baseline…”
Get full text

Are the properties of peripheral blood lymphocytes of patients with prostate cancer connected with the efficiency of radiation therapy? by Pelevina, I I, Aleshchenko, A V, Antoshhina, M M, Biriukov, V A, Kariakin, O B, Kudriashova, O V, Nikonova, M F, Minaeva, N G, Serebrianyĭ, A M, Iarilin, A A

“…The genome damage (frequency of cells with micronuclei and chromosome aberrations), concentration of reactive oxygen forms (ROS), markers of lymphocytes…”
Get more information

Genomic damage, adaptive response induction in blood lymphocytes at the prostate cancer patients. Connection with the tumour radiotherapy efficiency by Pelevina, I I, Aleshchenko, A V, Antoshchina, M M, Kudriashova, O V, Lizunova, E Iu, Minaeva, N G, Osipov, A N, Parshkov, E M, Riabchenko, N I, Sviridov, P V, Semenova, L P, Serebrianyĭ, A M

“…On the blood lymphocytes of prostate cancer (PCa) patients before and during radiotherapy: DNA damage by DNA commet assay (DNA double strand breaks - DSB); the…”
Get more information

The study on the assessment of the new levodopa drug--stalevo (levodopa/carbidopa/entacapone), in treatment of Parkinson's disease in out-patient clinical practice (the results of the open START-M) by Boĭko, A N, Batysheva, T T, Minaeva, N G, Babina, L A, Vdovichenko, T V, Zhuravleva, E Iu, Shikhkerimov, R K, Malykhina, E A, Khozova, A A, Zaĭtsev, K A, Kostenko, E V

“…Despite significant symptomatic effect of levodopa, in most patients the stable 24 hour's effect changed for alterations of movement symptoms (fluctuations,…”
Get more information

The radiosensitivity change after low-dose irradiation, possible mechanisms and regularities by Pelevina, I I, Aleshchenko, A V, Antoshchina, M M, Birjukov, V A, Reva, E V, Minaeva, N G

“…This paper is a short review of literature data and results of our own investigation into the adaptive response (AR). It was aimed at the analysis of the AR…”
Get more information

An estimation of individual radiosensitivity prostate malignant tumour cells using dynamic control of prostatic specific antigen level by Minaeva, N G, Parshkov, E M, Golivets, T P, Artamonova, Iu Z

“…Individual radiosensitivity of prostate malignant tumor cells were estimated in blood of 122 patients in accordance with the level of prostate-specific…”
Get more information